vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and PRICESMART INC (PSMT). Click either name above to swap in a different company.
PRICESMART INC is the larger business by last-quarter revenue ($1.4B vs $346.4M, roughly 4.0× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 28.1% vs 2.9%, a 25.2% gap on every dollar of revenue. On growth, PRICESMART INC posted the faster year-over-year revenue change (9.9% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $32.6M). Over the past eight quarters, PRICESMART INC's revenue compounded faster (3.5% CAGR vs 1.5%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
PRICESMART INCPSMTEarnings & Financial Report
PriceSmart, Inc. is a United States based operator of membership warehouse clubs in Central America, the Caribbean, and South America. PriceSmart was founded by Sol and Robert Price, founders of Price Club; Robert Price is chairman of the board.
HAE vs PSMT — Head-to-Head
Income Statement — Q4 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $346.4M | $1.4B |
| Net Profit | $97.3M | $40.2M |
| Gross Margin | 57.2% | 17.7% |
| Operating Margin | 36.1% | 4.6% |
| Net Margin | 28.1% | 2.9% |
| Revenue YoY | 4.8% | 9.9% |
| Net Profit YoY | — | 7.3% |
| EPS (diluted) | — | $1.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $346.4M | — | ||
| Q4 25 | $339.0M | $1.4B | ||
| Q3 25 | $327.3M | $1.3B | ||
| Q2 25 | $321.4M | $1.3B | ||
| Q1 25 | $330.6M | $1.4B | ||
| Q4 24 | $348.5M | $1.3B | ||
| Q3 24 | $345.5M | $1.2B | ||
| Q2 24 | $336.2M | $1.2B |
| Q1 26 | $97.3M | — | ||
| Q4 25 | $44.7M | $40.2M | ||
| Q3 25 | $38.7M | $31.5M | ||
| Q2 25 | $34.0M | $35.2M | ||
| Q1 25 | $58.0M | $43.8M | ||
| Q4 24 | $37.5M | $37.4M | ||
| Q3 24 | $33.8M | $29.1M | ||
| Q2 24 | $38.4M | $32.5M |
| Q1 26 | 57.2% | — | ||
| Q4 25 | 59.7% | 17.7% | ||
| Q3 25 | 59.5% | — | ||
| Q2 25 | 59.8% | — | ||
| Q1 25 | 58.4% | 17.1% | ||
| Q4 24 | 55.5% | 17.4% | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 52.0% | — |
| Q1 26 | 36.1% | — | ||
| Q4 25 | 19.9% | 4.6% | ||
| Q3 25 | 17.9% | 4.0% | ||
| Q2 25 | 16.8% | 4.3% | ||
| Q1 25 | 21.6% | 4.8% | ||
| Q4 24 | 16.9% | 4.6% | ||
| Q3 24 | 15.0% | 4.0% | ||
| Q2 24 | 11.8% | 4.1% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 13.2% | 2.9% | ||
| Q3 25 | 11.8% | 2.4% | ||
| Q2 25 | 10.6% | 2.7% | ||
| Q1 25 | 17.5% | 3.2% | ||
| Q4 24 | 10.8% | 3.0% | ||
| Q3 24 | 9.8% | 2.4% | ||
| Q2 24 | 11.4% | 2.6% |
| Q1 26 | — | — | ||
| Q4 25 | $0.95 | $1.29 | ||
| Q3 25 | $0.81 | $1.02 | ||
| Q2 25 | $0.70 | $1.14 | ||
| Q1 25 | $1.17 | $1.45 | ||
| Q4 24 | $0.74 | $1.21 | ||
| Q3 24 | $0.66 | $0.94 | ||
| Q2 24 | $0.74 | $1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.4M | $320.6M |
| Total DebtLower is stronger | $1.2B | $180.3M |
| Stockholders' EquityBook value | $796.3M | $1.3B |
| Total Assets | $2.4B | $2.4B |
| Debt / EquityLower = less leverage | 1.53× | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.4M | — | ||
| Q4 25 | $363.4M | $320.6M | ||
| Q3 25 | $296.4M | $314.2M | ||
| Q2 25 | $292.9M | $262.4M | ||
| Q1 25 | $306.8M | $247.3M | ||
| Q4 24 | $320.8M | $222.2M | ||
| Q3 24 | $299.3M | $225.5M | ||
| Q2 24 | $344.4M | $228.2M |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $180.3M | ||
| Q3 25 | $1.2B | $186.6M | ||
| Q2 25 | $1.2B | $103.1M | ||
| Q1 25 | $1.2B | $107.1M | ||
| Q4 24 | — | $115.6M | ||
| Q3 24 | — | $130.4M | ||
| Q2 24 | — | $135.1M |
| Q1 26 | $796.3M | — | ||
| Q4 25 | $911.5M | $1.3B | ||
| Q3 25 | $849.2M | $1.2B | ||
| Q2 25 | $882.3M | $1.2B | ||
| Q1 25 | $820.8M | $1.2B | ||
| Q4 24 | $906.9M | $1.2B | ||
| Q3 24 | $878.9M | $1.1B | ||
| Q2 24 | $905.4M | $1.1B |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $2.4B | ||
| Q3 25 | $2.4B | $2.3B | ||
| Q2 25 | $2.5B | $2.1B | ||
| Q1 25 | $2.5B | $2.1B | ||
| Q4 24 | $2.5B | $2.1B | ||
| Q3 24 | $2.5B | $2.0B | ||
| Q2 24 | $2.5B | $2.0B |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.34× | 0.14× | ||
| Q3 25 | 1.44× | 0.15× | ||
| Q2 25 | 1.39× | 0.08× | ||
| Q1 25 | 1.49× | 0.09× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $293.2M | $71.2M |
| Free Cash FlowOCF − Capex | $209.9M | $32.6M |
| FCF MarginFCF / Revenue | 60.6% | 2.4% |
| Capex IntensityCapex / Revenue | 9.5% | 2.8% |
| Cash ConversionOCF / Net Profit | 3.01× | 1.77× |
| TTM Free Cash FlowTrailing 4 quarters | $417.1M | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $293.2M | — | ||
| Q4 25 | $93.6M | $71.2M | ||
| Q3 25 | $111.3M | $82.1M | ||
| Q2 25 | $17.4M | $52.8M | ||
| Q1 25 | $116.6M | $87.9M | ||
| Q4 24 | $43.8M | $38.5M | ||
| Q3 24 | $48.8M | $41.8M | ||
| Q2 24 | $-27.4M | $38.1M |
| Q1 26 | $209.9M | — | ||
| Q4 25 | $87.2M | $32.6M | ||
| Q3 25 | $106.3M | $25.6M | ||
| Q2 25 | $13.6M | $14.0M | ||
| Q1 25 | $100.9M | $53.2M | ||
| Q4 24 | $35.2M | $10.3M | ||
| Q3 24 | $39.4M | $15.2M | ||
| Q2 24 | $-33.1M | $-308.0K |
| Q1 26 | 60.6% | — | ||
| Q4 25 | 25.7% | 2.4% | ||
| Q3 25 | 32.5% | 1.9% | ||
| Q2 25 | 4.2% | 1.1% | ||
| Q1 25 | 30.5% | 3.9% | ||
| Q4 24 | 10.1% | 0.8% | ||
| Q3 24 | 11.4% | 1.2% | ||
| Q2 24 | -9.8% | -0.0% |
| Q1 26 | 9.5% | — | ||
| Q4 25 | 1.9% | 2.8% | ||
| Q3 25 | 1.5% | 4.2% | ||
| Q2 25 | 1.2% | 2.9% | ||
| Q1 25 | 4.7% | 2.5% | ||
| Q4 24 | 2.5% | 2.2% | ||
| Q3 24 | 2.7% | 2.2% | ||
| Q2 24 | 1.7% | 3.1% |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.09× | 1.77× | ||
| Q3 25 | 2.88× | 2.60× | ||
| Q2 25 | 0.51× | 1.50× | ||
| Q1 25 | 2.01× | 2.01× | ||
| Q4 24 | 1.17× | 1.03× | ||
| Q3 24 | 1.44× | 1.44× | ||
| Q2 24 | -0.71× | 1.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
PSMT
| Fresh Foods | $454.9M | 33% |
| Caribbean Operations Segment | $396.5M | 29% |
| Colombia Operations Segment | $204.1M | 15% |
| Hardlines | $162.6M | 12% |
| Softlines | $99.8M | 7% |
| ship Income Member | $24.5M | 2% |
| Health Services | $14.5M | 1% |
| Other Revenue And Income | $4.2M | 0% |
| United States Operations Segment | $510.0K | 0% |
| Export Sales | $359.0K | 0% |
